Search Results

Population‐wide long‐term study of incidence, renal failure, and mortality rates for lupus nephritis.

• Authors : Nossent, Johannes C.; Keen, Helen I.; Preen, David B.

Subjects: LUPUS nephritis; KIDNEY failure; DEATH rateWESTERN Australia

• Source: International Journal of Rheumatic Diseases; Feb2024, Vol. 27 Issue 2, p1-8, 8p

Record details

Targeting Fli‐1 and chemokine axis CXCL10/CXCL13/CXCR3 in systemic lupus erythematosus and lupus nephritis.

• Authors : Zhu, Da‐Yong

Subjects: CHEMOKINE receptors; SYSTEMIC lupus erythematosus; LUPUS nephritis

• Source: International Journal of Rheumatic Diseases; Feb2024, Vol. 27 Issue 2, p1-9, 9p

Record details

Poster Abstracts.

Subjects: LUPUS nephritis; BULLOUS pemphigoid; SEX factors in disease

• Source: International Journal of Rheumatic Diseases; Jan2024 Supplement 1, Vol. 27, p66-434, 369p

Record details

Phosphorylated vimentin at Ser72 is associated with epithelial–mesenchymal transition in lupus nephritis.

• Authors : Wang, Daji; Zhang, Fan; He, Jing

Subjects: LUPUS nephritis; EPITHELIAL-mesenchymal transition; VIMENTIN

• Source: International Journal of Rheumatic Diseases; Jan2024, Vol. 27 Issue 1, p1-10, 10p

Record details

A real‐world study on the association of clinical characteristics of systemic lupus erythematosus with flare.

• Authors : Wang, Xiangyu; Upreti, Bibhuti; Yang, Yifan

Subjects: LUPUS nephritis; SYSTEMIC lupus erythematosus; SJOGREN'S syndrome

• Source: International Journal of Rheumatic Diseases; Jan2024, Vol. 27 Issue 1, p1-4, 4p

Record details

Azathioprine hypersensitivity: A Sweet‐like syndrome.

• Authors : Sivanandam, Lokesh Koumar; Begum, Benazir; Martinez, Ernesto Calderon

Subjects: LUPUS nephritis; AZATHIOPRINE; LEUKOCYTOCLASTIC vasculitis

• Source: International Journal of Rheumatic Diseases; Jan2024, Vol. 27 Issue 1, p1-5, 5p

Record details

From concept to reality: CAR‐T therapy as a glimmer of hope for systemic lupus erythematosus patients.

• Authors : Lin, Chia‐Jen; Lee, Yung‐Heng; Shih, Po‐Cheng

Subjects: SYSTEMIC lupus erythematosus; REALITY therapy; LUPUS nephritis

• Source: International Journal of Rheumatic Diseases; Nov2023, Vol. 26 Issue 11, p2137-2140, 4p

Record details

Overlapping drug‐induced vasculitis, ANCA‐associated vasculitis, and lupus nephritis caused by low‐dose hydralazine.

• Authors : Bhatnagar, M.; Agaronov, A.; Sarkisyan, E.

Subjects: LUPUS nephritis; DRUG side effects; HYDRALAZINE

• Source: International Journal of Rheumatic Diseases; Nov2023, Vol. 26 Issue 11, p2272-2277, 6p

Record details

Outlook of the jakinibs in systemic lupus erythematous after baricitinib failed.

• Authors : Mok, Chi Chiu

Subjects: LUPUS nephritis; AUTOIMMUNE diseases; BARICITINIB

• Source: International Journal of Rheumatic Diseases; Feb2024, Vol. 27 Issue 2, p1-3, 3p

Record details

Montelukast as a treatment for refractory cutaneous lupus: A case series.

• Authors : Rocha, Francisco Airton Castro; da Silva, Guilherme Ferreira Maciel; Nogueira, Igor Albuquerque

Subjects: LUPUS nephritis; SYSTEMIC lupus erythematosus; MONTELUKASTKING, Martin Luther, Jr., 1929-1968

• Source: International Journal of Rheumatic Diseases; Sep2023, Vol. 26 Issue 9, p1816-1820, 5p

Record details